Cargando…
Capecitabine inhibits epithelial-to-mesenchymal transition and proliferation of colorectal cancer cells by mediating the RANK/RANKL pathway
Colorectal cancer (CRC) is the third most prevalent malignancy globally. Capecitabine is an important form of chemotherapy for colorectal cancer. The present study aims to investigate the underlying mechanism of action of the drug in CRC cells. In the present study, 50 pairs of CRC and adjacent norm...
Autores principales: | Shao, Minghai, Jiang, Caiping, Yu, Changhui, Jia, Haijian, Wang, Yanli, Mao, Xinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822391/ https://www.ncbi.nlm.nih.gov/pubmed/35154427 http://dx.doi.org/10.3892/ol.2022.13216 |
Ejemplares similares
-
CCL20 mediates RANK/RANKL-induced epithelial-mesenchymal transition in endometrial cancer cells
por: Liu, Yao, et al.
Publicado: (2016) -
OCT4 Potentiates Radio-Resistance and Migration Activity of Rectal Cancer Cells by Improving Epithelial-Mesenchymal Transition in a ZEB1 Dependent Manner
por: Shao, Minghai, et al.
Publicado: (2018) -
Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007) -
RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016) -
RANK/RANKL expression in prostate cancer
por: Ohtaka, Mari, et al.
Publicado: (2016)